Sierra Biopharma is Developing Antigen-Specific Therapy Targeting Autoimmune Diseases
Sierra Biopharma, a biotechnology startup founded on intellectual property developed by researchers at the University of California, Davis, is developing a new therapeutic approach to treat autoimmune diseases. Inventors and co-founders Robert Fairclough and Vu Trinh have set an initial focus on treating myasthenia gravis, a chronic autoimmune disease that affects 1.4 million people globally. […]